DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
130 hedge funds and large institutions have $1.1B invested in DIPLOMAT PHARMACY, INC. in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 45 reducing their positions, and 22 closing their positions.
50% more call options, than puts
Call options by funds: $6.4M | Put options by funds: $4.27M
27% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 22
13% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 45
3% more funds holding
Funds holding: 126 → 130 (+4)
33% less capital invested
Capital invested by funds: $1.66B → $1.1B (-$554M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$49.6M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$16.8M |
| 3 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
+$16.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.4M |
| 5 |
O
OppenheimerFunds
New York
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$66M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$21.8M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$9.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.06M |
| 5 |
Lazard Asset Management
New York
|
-$8.53M |
DPLO Hedge Fund Activity: Q3 2015 in Review
130 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2015, worth a combined $1.1B — down 33% from $1.66B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new DPLO positions and 22 closed out — a net gain of 6 holders — while 51 added to existing stakes and 45 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $49.6M. The largest seller was Lord, Abbett & Co, cutting an estimated $66M.
- 130 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2015, up from 126 in Q2 2015.
- Funds reported $1.1B of DIPLOMAT PHARMACY, INC. stock for Q3 2015, down 33% quarter-over-quarter.
- 28 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2015 and 22 closed out, a net change of +6 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2015 was Waddell & Reed Financial, an estimated $49.6M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q3 2015 was Lord, Abbett & Co, an estimated $66M sold.
Based on aggregated 13F filings for Q3 2015.